Scientific Industries (OTCQB:SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems under the product name Cell Growth Quantifier and Liquid Injection System. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com.
Company profile
Ticker
SCND
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
42217279
Latest filings (excl ownership)
DEF 14A
Definitive proxy
15 Apr 24
8-K
Departure of Directors or Certain Officers
15 Apr 24
8-K
Departure of Directors or Certain Officers
8 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
S-1
IPO registration
15 Mar 24
8-K
Departure of Directors or Certain Officers
7 Mar 24
D
$7.00 mm in equity / options, sold $7.00 mm, 58 investors
1 Feb 24
8-K
Unregistered Sales of Equity Securities
22 Jan 24
8-K
Unregistered Sales of Equity Securities
22 Dec 23
8-K
Entry into a Material Definitive Agreement
15 Dec 23
Latest ownership filings
SC 13G/A
NORTH RUN CAPITAL, LP
21 Mar 24
SC 13G/A
SATTERFIELD THOMAS A JR
14 Feb 24
3
TODD B HAMMER
14 Feb 24
SC 13G
NORTH RUN CAPITAL, LP
14 Feb 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
4
JOHN A MOORE
29 Jan 24
4
JOHN A MOORE
29 Jan 24
4
JOHN A MOORE
29 Jan 24
4
HELENA R SANTOS
29 Jan 24
4
Marcus Frampton
17 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 515.40 k | 515.40 k | 515.40 k | 515.40 k | 515.40 k | 515.40 k |
Cash burn (monthly) | 43.03 k | 204.64 k | 741.80 k | 719.03 k | 387.30 k | 523.99 k |
Cash used (since last report) | 294.22 k | 1.40 mm | 5.07 mm | 4.92 mm | 2.65 mm | 3.58 mm |
Cash remaining | 221.18 k | -883.74 k | -4.56 mm | -4.40 mm | -2.13 mm | -3.07 mm |
Runway (months of cash) | 5.1 | -4.3 | -6.1 | -6.1 | -5.5 | -5.9 |
Institutional ownership, Q3 2023
9.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 953.72 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Veradace Capital Management | 953.72 k | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 24 | Helena R Santos | Common Stock | Buy | Acquire P | No | No | 2 | 11 | 22.00 | 258,288 |
17 Jan 24 | Helena R Santos | Warrants to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 2.5 | 11 | 27.50 | 234,343 |
20 Dec 23 | Jurgen Walter Schumacher | Common Stock | Grant | Acquire A | Yes | No | 2 | 67,500 | 135.00 k | 80,131 |
20 Dec 23 | Jurgen Walter Schumacher | Warrants Commons Stock | Grant | Acquire A | Yes | No | 2.5 | 67,500 | 168.75 k | 80,131 |
20 Dec 23 | John A Moore | Common stock | Buy | Acquire P | No | No | 2 | 2,030 | 4.06 k | 398,290 |
20 Dec 23 | John A Moore | Warrants to Purchase Common Stock Common Stock | Buy | Acquire P | No | No | 2.5 | 2,030 | 5.08 k | 293,508 |
Press releases
Scientific Industries Announces Appointment of Industry Leader Michael Blechman as New Board Member
16 Apr 24
Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024
1 Apr 24
Scientific Industries Reports Financial Results for Full Year Ended December 31, 2023 and Launches New VIVID-LITE S Pill Counter
1 Apr 24
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
8 Mar 24